Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Depreciation ExpenseEBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares Issued
Ratios

Akebia Therapeutics (AKBA) Shares Issued (2016 - 2025)

Historic Shares Issued for Akebia Therapeutics (AKBA) over the last 10 years, with Q2 2025 value amounting to $1.5 million.

  • Akebia Therapeutics' Shares Issued changed N/A to $1.5 million in Q2 2025 from the same period last year, while for Sep 2025 it was $88.5 million, marking a year-over-year increase of 22761.78%. This contributed to the annual value of $42.5 million for FY2024, which is 53349.73% up from last year.
  • Latest data reveals that Akebia Therapeutics reported Shares Issued of $1.5 million as of Q2 2025.
  • In the past 5 years, Akebia Therapeutics' Shares Issued ranged from a high of $72.4 million in Q4 2021 and a low of -$1000.0 during Q4 2022
  • Its 5-year average for Shares Issued is $17.4 million, with a median of $6.5 million in 2022.
  • In the last 5 years, Akebia Therapeutics' Shares Issued tumbled by 10000.14% in 2022 and then soared by 66250000.0% in 2023.
  • Quarter analysis of 5 years shows Akebia Therapeutics' Shares Issued stood at $72.4 million in 2021, then crashed by 100.0% to -$1000.0 in 2022, then surged by 662500.0% to $6.6 million in 2023, then surged by 233.53% to $22.1 million in 2024, then crashed by 93.02% to $1.5 million in 2025.
  • Its last three reported values are $1.5 million in Q2 2025, $64.9 million for Q1 2025, and $22.1 million during Q4 2024.